TABLE 1.
Demographics of patients prescribed new cancer drugs in Japan, January 2011‐December 2015
| Degarelix acetate | Axitinib | Pazopanib | Regorafenib | Pertuzumab | Ado‐trastuzumab emtansine | Afatinib | Trifluridine | Enzalutamide | Abiraterone acetate | Nivolumab | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | 55,083 | 12,387 | 11,226 | 17,737 | 15,808 | 7572 | 15,600 | 25,026 | 38,015 | 26,248 | 28,831 |
| Male (%) | All | 9294 (75.0) | 6805 (60.6) | 11,030 (62.2) | 58 (0.4) | 27 (0.4) | 6336 (40.6) | 15,012 (60.0) | All | All | 20,947 (72.7) |
| Age, y (SD) | 75.3 (8.2) | 67.5 (10.3) | 63.2 (15.3) | 65.8 (10.2) | 59.7 (11.7) | 59.9 (11.5) | 67.0 (10.2) | 67.0 (10.2) | 77.4 (7.7) | 77 (7.7) | 67.2 (10.2) |
| First prescription overall a | 2012/10 | 2012/8 | 2012/11 | 2013/5 | 2013/9 | 2014/4 | 2014/5 | 2014/5 | 2014/5 | 2014/9 | 2014/9 |
| First prescription in the slowest prefecture a | 2012/12 | 2013/8 | 2013/7 | 2013/8 | 2013/10 | 2014/8 | 2014/7 | 2014/6 | 2014/6 | 2014/9 | 2015/6 |
| Indication | Prostate | Renal cell | Renal cell, sarcoma |
Colorectal GIST Hepatic cell |
Breast | Breast | Lung |
Colorectal Gastric |
Prostate | Prostate |
Lung Melanoma Others |
Abbreviation: GIST, gastrointestinal stromal tumor.
a
Data are shown as year/month.